Group One Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-380,800
Closed -$37.8M 6016
2019
Q3
$37.8M Sell
380,800
-200
-0.1% -$19K 0.31% 37
2019
Q2
$35.2M Sell
381,000
-400,600
-51% -$38M 0.32% 36
2019
Q1
$73.7M Buy
781,600
+144,500
+23% +$12.6M 0.82% 3
2018
Q4
$40.8M Buy
637,100
+182,600
+40% +$13.5M 0.35% 40
2018
Q3
$40.7M Buy
454,500
+127,400
+39% +$11.3M 0.32% 40
2018
Q2
$26M Buy
327,100
+23,900
+8% +$1.98M 0.22% 74
2018
Q1
$27M Buy
303,200
+157,300
+108% +$15.1M 0.27% 53
2017
Q4
$15.2M Buy
145,900
+38,900
+36% +$4.39M 0.11% 208
2017
Q3
$15.6M Buy
107,000
+41,500
+63% +$5.65M 0.14% 143
2017
Q2
$8.51M Buy
65,500
+32,500
+98% +$3.98M 0.09% 255
2017
Q1
$4.11M Sell
33,000
-6,900
-17% -$826K 0.05% 488
2016
Q4
$4.62M Buy
39,900
+21,000
+111% +$2.34M 0.04% 471
2016
Q3
$1.98M Sell
18,900
-27,600
-59% -$2.99M 0.02% 860
2016
Q2
$4.59M Buy
46,500
+26,200
+129% +$2.71M 0.05% 430
2016
Q1
$2.03M Sell
20,300
-19,100
-48% -$1.97M 0.03% 759
2015
Q4
$4.72M Buy
39,400
+19,000
+93% +$2.2M 0.06% 400
2015
Q3
$2.21M Buy
20,400
+5,600
+38% +$695K 0.03% 725
2015
Q2
$1.71M Buy
+14,800
New +$1.69M 0.02% 848

Other funds holding CELG

Group One Trading's CELG Position: Q3 2019 in Review

Group One Trading sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 52,944 shares — an estimated $5.03M sold.

Group One Trading first reported a position in CELG in Q1 2015 and held it in 15 quarters. The position peaked at $12.7M in Q1 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Group One Trading reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 52,944 Celgene Corp shares in Q3 2019, an estimated $5.03M.
  • Group One Trading first reported a position in Celgene Corp in Q1 2015 and held it in 15 quarters.
  • Group One Trading's Celgene Corp position peaked at $12.7M in Q1 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.